(2021). Pembrolizumab: Guillain Barre Syndrome: case report. Reactions Weekly.
Chicago Style aipamena"Pembrolizumab: Guillain Barre Syndrome: Case Report." Reactions Weekly 2021.
MLA aipamena"Pembrolizumab: Guillain Barre Syndrome: Case Report." Reactions Weekly 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.